Greenwich, CTCIK 12814464 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
29 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Apogee Therapeutics Inc | 374.0K | $28.23M | 9.2% | +70.0K | Added |
| 2 | Amylyx Pharmaceuticals Inc | 1.75M | $21.14M | 6.9% | +50.0K | Added |
| 3 | Zura Bio Ltd | 3.82M | $20.00M | 6.5% | 0 | Held |
| 4 | Disc Medicine Inc |
| 250.0K |
| $19.85M |
| 6.4% |
| +250.0K |
| New |
| 5 | Rapt Therapeutics Inc | 581.2K | $19.68M | 6.4% | +581.2K | New |
| 6 | Immunovant Inc | 750.0K | $19.07M | 6.2% | +250.0K | Added |
| 7 | Soleno Therapeutics Inc | 400.0K | $18.52M | 6.0% | +175.0K | Added |
| 8 | Vor Biopharma Inc | 1.37M | $17.92M | 5.8% | +1.37M | New |
| 9 | Dianthus Therapeutics Inc | 350.0K | $14.42M | 4.7% | +84.2K | Added |
| 10 | Jade Biosciences Inc | 806.3K | $12.44M | 4.0% | +173.7K | Added |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio